http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0240351-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
filingDate 1987-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1992-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0240351-B1
titleOfInvention Method of preparing controlled longacting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
abstract A method of preparing a multiplicity of controlled, long-acting release pharmaceutical tablets, each containing a therapeutic agent and a cellulosic ether carrier base material is shown. The method includes the steps of adding a quantity of cellulose ether base material such as hydroxypropyl methylcellulose and an active therapeutic agent to form a mixture, thoroughly and uniformly mixing that mixture, discontinuing the mixing, permitting the uniform mixture to stand for a period of time, typically two to twenty-four hours or longer, sufficient to cause the therapeutic agent to become bonded to the carrier base material and compressing portions of the mixture to form the solid unit dose tablets. The advantage of the method is that the time release of each tablet from a given batch of formulation and the time release characteristics of tablets prepared in different batches, will be substantially more uniform and comparable.
priorityDate 1986-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129859949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6537503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136080371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12402726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226471503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226672118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129859948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127829488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128756335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128627107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5333

Total number of triples: 43.